Brief: Nextcell Pharma's Rights Issue Oversubscribed

NextCell Pharma AB

23/12/2020 10:51

Dec 23 (Reuters) - NextCell Pharma AB  NXTCL.ST :
    * NEXTCELL PHARMA'S RIGHTS ISSUE WAS OVERSUBSCRIBED
    * ANNOUNCES TODAY OUTCOME IN COMPANY'S NEW ISSUE OF SHARES
WITH
PREFERENTIAL RIGHTS FOR EXISTING SHAREHOLDERS OF ABOUT SEK 150
MILLION

Source text for Eikon:  ID:nWkr6Gwvfm 
Further company coverage:  NXTCL.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))